News & Analysis
The Problem with Current Vaccine Trials: What Journalists Need to be Asking Drug Companies
People around the world believe the several promising COVID-19 vaccines were designed to do the two things we most want them to do: reduce severe illness and death, and reduce the spread of the disease. But a central problem, experts say, is that none of the new vaccine trials were designed to achieve either of those goals.
